Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMC 2780811)

Published in Proc Natl Acad Sci U S A on October 30, 2009

Authors

Helen M McGuire1, Alexis Vogelzang, Natasha Hill, Malin Flodström-Tullberg, Jonathan Sprent, Cecile King

Author Affiliations

1: Department of Immunology, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst NSW 2010, Australia.

Articles citing this

Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes. Immunity (2015) 1.91

Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol (2010) 1.58

IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J Immunol (2010) 1.28

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes (2011) 1.11

Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum (2011) 0.98

Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol Metab Clin North Am (2010) 0.97

Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A (2013) 0.96

Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes. J Immunol (2013) 0.88

A recombination hotspot leads to sequence variability within a novel gene (AK005651) and contributes to type 1 diabetes susceptibility. Genome Res (2010) 0.88

Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity. Eur J Immunol (2011) 0.88

CD4 T cell differentiation in type 1 diabetes. Clin Exp Immunol (2015) 0.86

Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes. Am J Pathol (2011) 0.83

β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice. Diabetes (2013) 0.83

Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis (2012) 0.83

Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background. J Autoimmun (2013) 0.82

Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease. Rev Diabet Stud (2012) 0.80

Cellular mechanisms of restored β-cell tolerance mediated by protective alleles of Idd3 and Idd5. Diabetes (2011) 0.79

IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2. Nat Commun (2017) 0.79

Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells. Clin Exp Immunol (2013) 0.78

Congenic mice reveal genetic epistasis and overlapping disease loci for autoimmune diabetes and listeriosis. Immunogenetics (2014) 0.78

Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes. Rev Diabet Stud (2012) 0.78

Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice. PLoS One (2014) 0.77

A T cell extrinsic mechanism by which IL-2 dampens Th17 differentiation. J Autoimmun (2015) 0.77

Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springerplus (2016) 0.75

Sleeping Beauty Transposon Mutagenesis as a Tool for Gene Discovery in the NOD Mouse Model of Type 1 Diabetes. G3 (Bethesda) (2015) 0.75

The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis. Mamm Genome (2016) 0.75

Articles cited by this

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet (2007) 19.04

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 15.44

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med (2005) 7.87

Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science (2006) 6.38

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86

Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet (2007) 5.68

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell (2004) 5.59

Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol (2008) 4.90

Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol (2005) 3.82

A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res (1999) 3.68

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol (2007) 2.99

Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet (2007) 2.89

Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med (2005) 2.05

Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98

The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci U S A (2008) 1.85

IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A (2008) 1.74

Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity (2001) 1.72

Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol (1988) 1.63

Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes (2009) 1.53

Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc Natl Acad Sci U S A (2007) 1.51

IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Blood (2007) 1.50

Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J Immunol (1988) 1.49

Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem (2005) 1.47

NFATc2 and T-bet contribute to T-helper-cell-subset-specific regulation of IL-21 expression. Proc Natl Acad Sci U S A (2005) 1.45

Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology (2007) 1.35

Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res (2000) 1.34

Alternative pathways for the selection of antigen-specific peripheral T cells. Nature (1996) 1.33

IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS One (2008) 1.28

Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine (2000) 1.23

Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes (1997) 1.13

A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol (1997) 1.08

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J Immunol (2006) 0.97

Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. Mol Cell Biol (2005) 0.96

Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse. Proc Natl Acad Sci U S A (2009) 0.88

Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes. Int Immunol (1994) 0.86

Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells. Eur J Immunol (1994) 0.83

Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice. Eur J Immunol (1992) 0.80

Articles by these authors

Homeostasis of naive and memory T cells. Immunity (2008) 7.48

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59

A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity (2008) 6.41

Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science (2006) 6.38

The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol (2012) 3.97

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med (2009) 3.78

Homeostasis of memory T cells. Immunol Rev (2006) 3.69

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 3.58

Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med (2002) 3.20

Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J Exp Med (2002) 3.06

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A (2006) 3.04

IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol (2008) 2.58

Cytokines and T-cell homeostasis. Curr Opin Immunol (2007) 2.58

B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med (2010) 2.42

Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med (2007) 2.29

ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes. Nat Immunol (2011) 2.21

Regulation of mature T cell homeostasis. Semin Immunol (2005) 2.17

T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity (2010) 2.17

IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc Natl Acad Sci U S A (2004) 1.79

Homeostatic proliferation and survival of naïve and memory T cells. Eur J Immunol (2009) 1.71

Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol (2006) 1.69

Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies. Nat Biotechnol (2006) 1.66

Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther (2006) 1.61

An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med (2007) 1.59

Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol (2009) 1.50

IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25. Proc Natl Acad Sci U S A (2010) 1.50

Regulation of naive T cell function by the NF-kappaB2 pathway. Nat Immunol (2006) 1.49

Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes (2008) 1.46

IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med (2010) 1.41

Interferons induce an antiviral state in human pancreatic islet cells. Virology (2007) 1.41

Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci U S A (2003) 1.38

IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J Immunol (2008) 1.38

The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol (2003) 1.31

Regulation of naïve and memory T-cell homeostasis. Microbes Infect (2002) 1.25

CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest (2014) 1.24

Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J Exp Med (2002) 1.24

A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J Exp Med (2006) 1.15

Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur J Immunol (2014) 1.15

Lineage specification and heterogeneity of T follicular helper cells. Curr Opin Immunol (2009) 1.14

Homeostatic maintenance of T cells and natural killer cells. Cell Mol Life Sci (2012) 1.13

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes (2011) 1.11

IL-21-producing Th cells in immunity and autoimmunity. J Immunol (2013) 1.09

Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol (2010) 1.08

A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity. Immunity (2011) 1.05

Emerging cellular networks for regulation of T follicular helper cells. Trends Immunol (2011) 1.02

The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J Immunol (2008) 0.99

Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes (2011) 0.99

SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J (2012) 0.97

Direct stimulation of T cells by membrane vesicles from antigen-presenting cells. Proc Natl Acad Sci U S A (2006) 0.96

IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD. J Am Soc Nephrol (2012) 0.96

Interleukin-27 signaling promotes immunity against endogenously arising murine tumors. PLoS One (2013) 0.96

The TheraCyte™ device protects against islet allograft rejection in immunized hosts. Cell Transplant (2012) 0.93

Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol (2013) 0.91

CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells. BMC Med (2014) 0.90

Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection. Virology (2010) 0.89

Unique features of naive CD8+ T cell activation by IL-2. J Immunol (2013) 0.86

The target tissue in autoimmunity--an influential niche. Eur J Immunol (2007) 0.85

Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Transplantation (2005) 0.84

Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts. Blood (2011) 0.84

The role of interleukin-2 in memory CD8 cell differentiation. Adv Exp Med Biol (2010) 0.84

Measurement of T and B cell turnover with bromodeoxyuridine. Curr Protoc Immunol (2007) 0.84

The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice. PLoS One (2013) 0.83

Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter]. Diabetologia (2014) 0.83

Knowing one's self: central tolerance revisited. Nat Immunol (2003) 0.83

Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells. J Immunol (2012) 0.83

Interleukin 7, maestro of the immune system. Semin Immunol (2012) 0.83

T helper cell differentiation: IL-21 and T helper cell differentiation: Jack of all trades? Immunol Cell Biol (2008) 0.81

Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells? Nat Immunol (2010) 0.81

Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts. Ann N Y Acad Sci (2008) 0.80

IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells. J Immunol (2014) 0.80

IFN-gamma production dominates the early human natural killer cell response to Coxsackievirus infection. Cell Microbiol (2007) 0.80

Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death. Cell Mol Life Sci (2009) 0.80

Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. Cell Immunol (2009) 0.79

Recent acquisitions on the genetic basis of autoimmune disease. Front Biosci (2008) 0.79

Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses. Cancer Res (2011) 0.79

A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia (2014) 0.78

Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling. Transpl Immunol (2010) 0.78

TGF-β puts the brakes on homeostatic proliferation. Nat Immunol (2012) 0.78

The modulatory capacity of interleukin-21 in the pathogenesis of autoimmune disease. Front Biosci (2008) 0.78

Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells. Transplantation (2012) 0.78

On the TRAIL of homeostatic memory T cells. Nat Immunol (2006) 0.77

Staying alive--naïve CD4(+) T cell homeostasis. Eur J Immunol (2007) 0.77

Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice. J Pediatr Gastroenterol Nutr (2008) 0.77

Glimpsing the real CD4+ T cell response. Nat Immunol (2010) 0.77

Expression, purification and characterization of recombinant interleukin-21. J Immunol Methods (2010) 0.76

Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages. Diabetes (2013) 0.76

Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells. Blood (2011) 0.76

CD70-CD27 ligation between neural stem cells and CD4+ T cells induces Fas-FasL-mediated T-cell death. Stem Cell Res Ther (2013) 0.75